- Home
- EBON vs ALUR Comparison
EBON vs ALUR Comparison
Compare EBON & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EBON | ALUR |
|---|---|---|
| Founded | 2010 | 2009 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | |
| Sector | Technology | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.4M | 18.9M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | EBON | ALUR |
|---|---|---|
| Price | $3.50 | $1.43 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | 9.1K | ★ 113.3K |
| Earning Date | 08-15-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $7,337,066.00 | ★ $17,208,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $9.02 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 104.28 | N/A |
| 52 Week Low | $3.00 | $1.02 |
| 52 Week High | $7.15 | $16.81 |
Technical Indicators
Market Signals| Indicator | EBON | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 38.20 | 41.88 |
| Support Level | $3.31 | $1.31 |
| Resistance Level | $3.63 | $1.71 |
| Average True Range (ATR) | 0.18 | 0.12 |
| MACD | 0.02 | -0.00 |
| Stochastic Oscillator | 11.12 | 29.45 |
Price Performance
Historical ComparisonAbout EBON Ebang International Holdings Inc.
Ebang International Holdings Inc is a blockchain technology and Fintech company, that has ASIC chip design capability. Its business is ASIC chip design and Telecommunication. It operates in a single segment selling bitcoin mining machines and related accessories, telecommunication products, providing cryptocurrency exchange services, management and maintenance services, and cross-border payment and foreign exchange services and rental services. Its geographic regions are Mainland China, and Australia.
About ALUR Allurion Technologies Inc.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.